Medicated Skin Care in Brazil

Euromonitor International's Medicated Skin Care in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

• Get a detailed picture of the medicated skin care industry
• Identify factors driving change
• Understand the competitive environment, the market's major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

• Medicated Skin Care in Brazil
• Euromonitor International
• May 2009
• Positive Economy Indicators Push Sales of OTC Healthcare
• New Rules for OTC Advertising
• Hypermarcas Acquires Dm Indústria Farmacêutica and Farmasa
• Further Consolidation of Drugstores
• Slowdown Growth in the Next Two Years
• Key Trends and Developments
• Further Restriction To Advertising of OTC Products
• Hypermarcas Acquires Two Leading OTC Manufacturers
• Specific Department for OTC Products Established Within Anvisa
• Financial Crisis Affects OTC Products
• Senior Consumers and Women Over 40 Years Old Attract Investment
• Market Indicators
• Market Data
• OTC Registration and Classification
• De-reimbursement
• Advertising
• Packaging and Labelling
• Distribution
• Vitamins and Dietary Supplements Registration and Classification
• Self-medication and Preventative Medicine
• Generics
• Switches
• Definitions
• Aché Laboratórios Farmacêuticos SA
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Bayer SA
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Dm Indústria Farmacêutica Ltda
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Ems SA
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Eurofarma Laboratório Ltda
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Janssen-cilag Farmaceutica Ltda
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Medley SA Indústria Farmacêutica
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Nycomed Pharma Ltda
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Sanofi-aventis Farmacêutica Ltda
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Headlines
• Trends
• Switches
• Competitive Landscape
• Prospects
• Sector Data
• List of Summaries
  • Summary 1 OTC Healthcare Switches 2005-2007
  • Summary 2 Research Sources
  • Summary 3 Aché Laboratórios Farmacêuticos SA: Key Facts
  • Summary 4 Aché Laboratórios Farmacêuticos SA: Operational Indicators
  • Summary 5 Aché Laboratórios Farmacêuticos SA: Production Statistics 2007
  • Summary 6 Aché Laboratórios Farmacêuticos SA: Competitive Position 2008
  • Summary 7 Bayer SA: Key Facts
  • Summary 8 Bayer SA: Operational Indicators
  • Summary 9 Bayer SA: Competitive Position 2008
  • Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
  • Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Operational Indicators
  • Summary 12 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2007
  • Summary 13 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2008
  • Summary 14 DM Indústria Farmacêutica Ltda: Key Facts
  • Summary 15 DM Indústria Farmacêutica Ltda: Operational Indicators
  • Summary 16 DM Indústria Farmacêutica Ltda: Competitive Position 2008
  • Summary 17 EMS SA: Key Facts
  • Summary 18 EMS SA: Operational Indicators
  • Summary 19 EMS SA: Production Statistics 2007
  • Summary 20 EMS SA: Competitive Position 2008
  • Summary 21 Eurofarma Laboratório Ltda: Key Facts
  • Summary 22 Eurofarma Laboratório Ltda: Operational Indicators
  • Summary 23 Eurofarma Laboratório Ltda: Production Statistics 2007
  • Summary 24 Eurofarma Laboratório Ltda: Competitive Position 2008
  • Summary 25 Janssen-Cilag Farmacêutica Ltda: Key Facts
  • Summary 26 Janssen-Cilag Farmacêutica Ltda: Competitive Position 2008
  • Summary 27 Medley SA Indústria Farmacêutica: Key Facts
  • Summary 28 Medley SA Indústria Farmacêutica: Operational Indicators
  • Summary 29 Medley SA Indústria Farmacêutica: Production Statistics 2007
  • Summary 30 Medley SA Indústria Farmacêutica: Competitive Position 2008
  • Summary 31 Nycomed Pharma Ltda: Key Facts
  • Summary 32 Nycomed Pharma Ltda: Operational Indicators
  • Summary 33 Nycomed Pharma Ltda: Production Statistics 2007
  • Summary 34 Nycomed Pharma Ltda: Competitive Position 2008
  • Summary 35 Sanofi-Aventis Farmacêutica Ltda: Key Facts
  • Summary 36 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
  • Summary 37 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2008
• List of Tables
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
  • Table 2 Life Expectancy at Birth 2003-2008
  • Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
  • Table 5 OTC Healthcare Company Shares by Value 2004-2008
  • Table 6 OTC Healthcare Brand Shares by Value 2005-2008
  • Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
  • Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
  • Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
  • Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
  • Table 11 Sales of Medicated Skin Care by Subsector: Value 2003-2008
  • Table 12 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
  • Table 13 Herbal vs Standard Medicated Skin Care 2003-2008
  • Table 14 Acne Treatments by Format: % Value Breakdown 2004-2008
  • Table 15 Medicated Skin Care Company Shares by Value 2004-2008
  • Table 16 Medicated Skin Care Brand Shares by Value 2005-2008
  • Table 17 Acne Treatments Brand Shares by Value 2005-2008
  • Table 18 Hair Loss Treatments Brand Shares by Value 2005-2008
  • Table 19 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
  • Table 20 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013